Fosamax and Fractured Femur Injuries
New York Drug Liability Attorneys
Experienced in Litigating Fosamax Liability Cases
(We are no longer accepting new cases, but we continue to litigate on behalf of the many clients we already have.)
With Rheingold Giuffra Ruffo & Plotkin LLP you are getting a firm who has represented Fosamax clients since 2006. Our firm has one of the few "bellwether" femur fracture cases. These are hand-picked cases from the thousands of pending suits which are chosen to be prosecuted as one of the first trials. As of early 2012, our firm is conducting deposition discovery of our client, a woman for South Carolina who has suffered from a femur fracture in each leg.
Aside from our firm prosecuting hundreds of individual claims, litigation involves review of millions of corporate documents. Perhaps these documents will reveal that Fosamax's benefits were significantly more narrow than promoted, and that the dangerous side effects were much more severe. Sadly, some of our femur fracture clients have not fully healed even after two years of recovery!
The drug Fosamax uses bisphosphonate to treat symptoms of bone disease and bone degeneration like osteoporosis. Unfortunately, a side effect of bisphosphonate and Fosamax is damage to bones. Specifically, Fosamax can lead to:
- The fracturing of the femur
- Damage to the jaw bone (often referred to as osteonecrosis of the jaw [ONJ])
Fosamax and bisphosphonate's damage is usually limited to the jaw and femur because it tends to "target" bones that have been subjected to heaviest impact, namely our femurs/hips (from walking) and jaws (from chewing).
Fosamax can damage femurs to such an extent that femur/hip breaks caused by Fosamax usually occur during routine activity like walking to a mailbox or even just standing. If you suspect that you or a loved one has experienced a fractured or broken femur following the use of Fosamax, contact the New York medical malpractice law firm of Rheingold Giuffra Ruffo & Plotkin LLP.
Our firm filed one of the first femur fracture cases in February, 2009, almost two years before the FDA required warnings about the injury (see below). We continue to review and file cases in a coordinated action with other firms in order combine forces for the strongest possible litigation. Drug companies selling bisphosphonates have attempted to thwart litigation, but our firm and the courts are now pushing the litigation based on the continued findings of medical studies. Through written discovery demands on the drug companies, we will learn more about what their actual knowledge was of the nine femur fracture victims reported in 2005 (some of which obviously happened before 2005), which is five years before the warning was added.
For knowledgeable legal help in New York regarding Fosamax femur and bone injuries, contact the lawyers of Rheingold Giuffra Ruffo & Plotkin LLP at (888) 260-0473
Fosamax injuries can strike any Fosamax user but most often affects older, female users. We regularly meet both with victims of Fosamax and the adult children of Fosamax users who are concerned about a parent's health.
More Information About Fosamax, Fractured Femurs and Rheingold Giuffra Ruffo & Plotkin LLP
The FDA is mandating a warning about femur fractures. See below for more information.
Research demonstrates that use of Fosamax may increase the risk of a rare type of femur fracture due to impacting the ability of the bone to repair damage to the femur.
The study is published in the May/June 2008 issue of the Journal of Orthopedic Trauma. Researchers performed a review of femur fractures which resulted in emergency room treatment between January 2002 and March 2007. The fractures reviewed in the observational study involved injuries typically caused by the impacts of falls from a standing height or less.
Researchers identified a fracture pattern that was 98% specific to users of Fosamax, and the average duration of Fosamax use was longer among those who had the pattern than those who did not. 25 involved users of Fosamax and 76% of the Fosamax femur fractures involved the distinct characteristics identified in the fracture pattern.
We are actively pursuing these cases, and please feel free to call us for a free and confidential consultation. We can handle cases in any state, and are already involved in the consolidated litigation against Merck for their Fosamax drug.
For many of our Fosamax patients a lawsuit is an opportunity to hold negligent doctors and drug manufacturers responsible for their carelessness. If you have questions regarding medical malpractice law and Fosamax litigation, contact a medical malpractice attorney in New York City by calling Rheingold Giuffra Ruffo & Plotkin LLP.
Rheingold Giuffra Ruffo & Plotkin LLP offers free initial consultations, works on a contingency fee basis and is conveniently located in Midtown Manhattan. To contact us, call (888) 260-0473